Related Experiment Video
Updated: Dec 4, 2025
Efficient Isolation Protocol for B and T Lymphocytes from Human Palatine Tonsils
Published on: November 16, 2015
A Child with Acute Lymphoblastic Leukemia in Institutional Isolation during the COVID Pandemic: A Multifaceted
Puneet Rathore1, Sanjeev Kumar1, Shweta1
1Department of Onco-Anaesthesia and Palliative Medicine, Dr. BRAIRCH, All India Institute of Medical Sciences, New Delhi, India.
Insights
The COVID-19 pandemic presents significant challenges, particularly for immunocompromised children with acute lymphoblastic leukemia (ALL). This case study highlights the management of a pediatric ALL patient who contracted COVID-19 during treatment.
Area of Science:
- Pediatric Oncology
- Infectious Diseases
- Hematology
Background:
- The COVID-19 pandemic poses unique risks to vulnerable populations, including children with cancer.
- Acute lymphoblastic leukemia (ALL) is the most prevalent malignancy in children, requiring intensive treatment.
- Comorbidities like hypertension and diabetes increase COVID-19 severity, as do immunocompromised states.
Observation:
- A 10-year-old boy diagnosed with ALL tested positive for COVID-19 during his treatment phase.
- The patient was admitted to a COVID isolation center for management.
- His mother, who accompanied him, tested negative for COVID-19.
Findings:
- This case underscores the complexities of managing pediatric cancer patients during the COVID-19 pandemic.
- It highlights the need for specialized care protocols for immunocompromised children with infections.
- The psychological and physical concerns for both the child and family are significant.
Implications:
- Effective strategies are crucial for preventing and managing COVID-19 in pediatric cancer patients.
- Integrated care models are needed to address the dual challenges of cancer treatment and infectious disease.
- Further research is warranted on the long-term outcomes and specific vulnerabilities of this patient group.
Abstract:
The occurrence of the COVID-19 pandemic has caused big challenges in medical communities due to its unpredictable and uncertain nature. It leads to a great deal of physical and psychological concerns. It is more prone to patients with comorbidities such as hypertension and diabetes mellitus and also to immune-compromised patients such as cancer patients. Children are no exception. Acute lymphoblastic leukemia (ALL) is the most common malignancy in the pediatric age group. In this case, we discuss the concerns and reflect the issues of a 10-year-old boy of ALL who was tested COVID positive during the evaluation and treatment of his disease and was admitted in a COVID isolation center along with his mother who was COVID negative.
